Concepedia

Tom Kouroukis

TK

4

Publications

93

Citations

4

H-Index

2016

Active since

Affiliations

Princess Margaret Cancer Centre(Current)

Juravinski Cancer Centre

CancerCare Manitoba

University of Manitoba

Ottawa Hospital Research Institute

Tom Kouroukis is an author at Princess Margaret Cancer Centre specializing in cancer research, hematology, and immunology.

Top concepts

Publications per year

2016–2016

4

Publications

4

The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group

Matthew D. Seftel, John Kuruvilla, Tom Kouroukis et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 47 citations

Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline

Anca Prica, Fulvia Baldassarre, Lisa K. Hicks et al. · Clinical Oncology · 2016 · 18 citations

, , +9

Selinexor in Combination with Bortezomib and Dexamethasone (SdB) Demonstrates Significant Activity in Patients with Refractory Multiple Myeloma (MM) Including Proteasome-Inhibitor Refractory Patients: Results of the Phase I Stomp Trial

Nizar J. Bahlis, Rami Kotb, Michaël Sébag et al. · Blood · 2016 · 17 citations

Selinexor Shows Synergy in Combination with Pomalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma

Christine Chen, Rami Kotb, Michaël Sébag et al. · Blood · 2016 · 11 citations

Rows per page

1–4 of 4